ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Abstract

Inter-α-inhibitor heavy chain 4 (ITIH4) is a poorly characterized plasma protein that is proteolytically processed in multiple pathological conditions. However, no biological function of ITIH4 has been identified. Here, we show that ITIH4 is cleaved by several human proteases within a protease-susceptible region, enabling ITIH4 to function as a protease inhibitor. This is exemplified by its inhibition of mannan-binding lectin-associated serine protease-1 (MASP-1), MASP-2, and plasma kallikrein, which are key proteases for intravascular host defense. Mechanistically, ITIH4 acts as bait that, upon cleavage, forms a noncovalent, inhibitory complex with the executing protease that depends on the ITIH4 von Willebrand factor A domain. ITIH4 inhibits the MASPs by sterically preventing larger protein substrates from accessing their active sites, which remain accessible and fully functional toward small substrates. Thus, we demonstrate that ITIH4 functions as a protease inhibitor by a previously undescribed inhibitory mechanism.

Original languageEnglish
Article number7381
JournalScience Advances
Volume7
Issue2
Number of pages17
ISSN2375-2548
DOIs
Publication statusPublished - Jan 2021

Keywords

  • ALPHA-TRYPSIN INHIBITOR
  • ALTERNATIVE PATHWAY
  • COMPLEMENT
  • FUNCTIONAL-ACTIVITY
  • HUMAN SERUM
  • INTER
  • LECTIN-PATHWAY ACTIVATION
  • MASP-1 NOR MASP-3
  • PLASMA KALLIKREIN
  • SEQUENCE

Fingerprint

Dive into the research topics of 'ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism'. Together they form a unique fingerprint.

Cite this